Phospholine Iodide Ophthalmic Drops, Powder For Solution 0.125pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Phospholine Iodide: Ophthalmic drops, powder for solution (0.125%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Phospholine 0.125% Ophth Pwd

What is this Medicine?

ECHOTHIOPHATE (ek oh THYE oh fate) works in the eye. It is used to treat some kinds of glaucoma. It is also used to diagnose and to treat a condition that causes the eyes to cross.

CVS Pharmacy Patient Statistics for Phospholine Iodide: Ophthalmic drops, powder for solution(0.125%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Phospholine Iodide 0.125% Ophthalmic Powder for Reconstitution

NDC: 000461065
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Glaucoma, Strabismus

Storage Information
Refrigerate (between 36 and 46 degrees F)
Reconstituted product may be stored at room temperature (approximately 77 degrees F) for up to 4 weeks
Phospholine Iodide 0.125% Ophthalmic Powder for Reconstitution
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Phospholine Iodide

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.